Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04956549 · ClinicalTrials.gov registry record · NA

Reducing African American's Alzheimer's Risk Through Exercise-Mild Cognitive Impairment (RAATE-MCI)

A NA study of Dementia of Alzheimer Type, sponsored by Pennington Biomedical Research Center.

Recruiting
Registry status
NA
Development phase
144
Enrollment target
1
Study location

NCT04956549 is a NA study of Dementia of Alzheimer Type that is actively recruiting participants, run by Pennington Biomedical Research Center. The registered enrollment target is 144 participants, below the 639-participant average among 10 other Dementia of Alzheimer Type trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04956549, a NA study of Dementia of Alzheimer Type, is actively recruiting participants, sponsored by Pennington Biomedical Research Center.

RECRUITING
Registry status
NA
Development phase
144 participants
Enrollment target
1
Study location

Study Summary

The RAATE-MCI proposal is designed to determine the effects of physical activity on risk factors for Alzheimer's Disease in older African American adults. The study will compare a physical activity program to an active control group. RAATE-MCI is a 52-week randomized controlled trial. 144 African American adults aged 60 and older will be recruited.

Conditions Studied

Interventions

  • BEHAVIORAL Successful Aging
  • BEHAVIORAL Physical activity program

Study Locations (1)

Louisiana

  • Pennington Biomedical Research - Baton Rouge

Trial Details

FieldValue
Enrollment Target 144 participants
Start Date 2021-06-01
Est. Completion 2027-03-31
Phase NA

What the Registry Record Tells You About NCT04956549

The ClinicalTrials.gov registry entry for NCT04956549 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 639-participant average among 10 other Dementia of Alzheimer Type trials with a reported enrollment target (77% lower). The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dementia of Alzheimer Type appearing as the primary indexed condition, and to 2 interventions - of which Successful Aging is the first listed.

NCT04956549 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.

Frequently Asked Questions

What is clinical trial NCT04956549 about?

NCT04956549 is a clinical study titled "Reducing African American's Alzheimer's Risk Through Exercise-Mild Cognitive Impairment (RAATE-MCI)". The RAATE-MCI proposal is designed to determine the effects of physical activity on risk factors for Alzheimer's Disease in older African American adults. The study will compare a physical activity program to an active control group. RAATE-MCI is a 52-week randomized controlled trial. 144 African Am...

What is the current status of trial NCT04956549?

This trial is currently recruiting. It is a NA study. The enrollment target is 144 participants. The study started on 2021-06-01. Estimated completion is 2027-03-31.

What conditions does trial NCT04956549 study?

This clinical trial studies the following conditions: Dementia of Alzheimer Type.

What interventions are being tested in trial NCT04956549?

The interventions under investigation include: Successful Aging (BEHAVIORAL), Physical activity program (BEHAVIORAL).

Who is sponsoring clinical trial NCT04956549?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04956549 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dementia of Alzheimer Type

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.